Binding Site has recently won The Queen's Award for Enterprise 2010, in the category International Trade, for its outstanding achievement in increasing export revenues by 74% to over £42 million/year in 3 years and selling more than 90% of its production overseas. Aggregate exports over this period totalled £96 million.

This exceptional growth is primarily driven by sales of Freelite®, a unique tumour marker for several bone marrow cell cancers (such as Multiple Myeloma) as well as AL amyloidosis and other B cell dyscrasias. Since the Freelite® free kappa and free lambda immunoglobulin light chain assays were launched in 2000, sales have grown exponentially up to £20 million/year in 2009. New jobs have been created in sales, marketing, research and clinical education, both in the UK and internationally, to support this trade.

This is Binding Site's 3rd Queen's Award for Enterprise. The first was awarded in 1992 also in the International Trade category and the second award was in 2007 in the category Innovation, for Freelite®.

Binding Site has been named as a winner of The Queen's Award for Enterprise in the category Innovation 2007.

The award has been granted in recognition of the development of Freelite®, a new diagnostic assay for the diagnosis and monitoring of multiple myeloma, a type of Bone Marrow cancer.

Launched in 2000 the Freelite® assay is used in hospital laboratories worldwide to help diagnose this cancer and to monitor the effectiveness of treatment in patients receiving chemotherapy. Previously used laboratory diagnostic techniques were not always as sensitive as the Freelite® assay which allows doctors to use a simple blood test to monitor their patients. In rare forms of the disease, monitoring with Freelite® is the only way of assessing whether a patient is responding to therapy or whether the therapy needs to be changed to better treat the patient. In this group of patients the Freelite® assay has revolutionised the way doctors can select the appropriate treatment for each individual patient.

The Queen's Award for Enterprise 2007 Innovation was presented to Binding Site by Sir Adrian Cadbury, deputy Lord Lieutenant of Warwickshire, during an afternoon of celebration at the company's headquarters in Birmingham, UK. The ceremony, held on 24th October 2007, was also attended by the Lord Mayor and Lady Mayoress of Birmingham, the Chancellor of the University of Birmingham, Sir Dominic Cadbury, plus colleagues from finance, medicine and business.